Brief: Sprint Bioscience Q1 operating loss narrows to SEK 2.8 million
May 18 (Reuters) - Sprint Bioscience AB SPRINT.ST :
* Q1 revenue 5.4 million Swedish crowns ($653,057) versus 1.7 million crowns year ago
* Q1 operating loss 2.8 million Swedish crowns versus loss 3.8 million crowns year ago
Source text for Eikon: ID:nWkreq1518
Further company coverage: SPRINT.ST
($1 = 8.2688 Swedish crowns)
(Gdynia Newsroom)
((gdynia.newsroom@thomsonreuters.com; +48 58 698 3920;))
Recent news on Sprint Bioscience AB
See all newsBrief: Sprint Bioscience Q1 Operating Loss SEK 14.3 Mln
Brief: Sprint Bioscience Completes Strategic Evaluation Of STK25 Program
Brief: Sprint Bioscience Appoints Jenni Björnulfson As CFO
Brief: Sprint Bioscience Reports Positive Proof-Of-Concept Results From Program In CKD
Brief: Sprint Bioscience Reports Positive Results From The Vrk1 Program